Financhill
Back

Soligenix 10K Form

Sell
36

SNGX
Soligenix

Last Price:
3.31
Seasonality Move:
111.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SNGX News And Ratings

See the #1 stock for the next 7 days that we like better than SNGX

SNGX Financial Statistics

Sales & Book Value

Annual Sales: $250K
Cash Flow: $-2.91M
Price / Cash Flow: 0
Annual Sales: $2.59
Price / Book: 1.4

Profitability

EPS (TTM): -7.56000
Net Income (TTM): $-7.1M
Gross Margin: $-742.05K
Return on Equity: 0%
Return on Assets: 0%

Soligenix Earnings Forecast

Key Soligenix Financial Ratios

  • The Selling, General & Administrative Expenses for SNGX have been equal to 2,677.16% of Gross Profit Margin.
  • The Interest Expense is -0.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 18 years.

Soligenix Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SNGX
CUSIP: 834223
Website: soligenix.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SNGX Technical Analysis vs Fundamental Analysis

Sell
36
Soligenix (SNGX) is a Sell

Is Soligenix a Buy or a Sell?

  • Soligenix stock is rated a Sell
    The current Soligenix [SNGX] share price is $3.32. The Score for SNGX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.